Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]

Syvälahti EKG, Kanto JH: Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man. Int J Clin Pharmacol. 1975, 12: 74-82.

Zumoff B, Hellman L: Aggravation of diabetic hyperglycemia by chlordiazepoxide. JAMA. 1977, 237: 1960-1961. 10.1001/jama.237.18.1960.

Langer SZ, Arbilla S: Imidazopyridines as a tool for the characterization of benzodiazepine receptors. Pharmacol Biochem Behav. 1988, 29: 763-766. 10.1016/0091-3057(88)90202-X.

Bottaï T, Cartault F, Pouget R, Blayac JP, Petit P: An imidazopyridine anxiolytic alters glucose tolerance in patients: a pilot investigation. Clin Neuropharmacol. 1995, 18: 79-82.

Petit P, Manteghetti M, Berdeu D, Ribes G, Loubatières-Mariani MM: Effects of a peripheral-type benzodiazepine on glucose-induced insulin secretion. European J Pharmacol. 1992, 221: 359-363. 10.1016/0014-2999(92)90723-H.

Marchetti P, Trincavelli L, Giannarelli R, Giusti L, Coppelli A, Martini C, Navalesi R, Lucacchini A: Characterization of peripheral benzodiazepine receptors in purified large mammal pancreatic islets. Biochem Pharmacol. 1996, 51: 1437-1442. 10.1016/0006-2952(96)00082-2.

Jing X, Wala EP, Sloan JW: The effects of chronic benzodiazepines exposure on body weight in rats. Pharmacol Res. 1998, 37: 179-189. 10.1006/phrs.1997.0289.

Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol. 1979, 236: E667-E677.

Wang JKT, Taniguchi T, Spector S: Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Mol Pharmacol. 1984, 25: 349-351.

Trinder P: Determination of blood glucose using an oxidase-peroxydase system with a non-carcinogenic chromogen. J Clin Pathol. 1969, 22: 158-161.

Crevat-Pisano P, Drouet C, Lacarelle B, Alazia M, Francois G, Cano JP: Validation of a radioreceptor assay technique for monitoring pharmacological active material during intensive diazepam tetanus therapy. Int J Clin Pharmacol Ther Toxicol. 1987, 25: 366-373.

Yang YJ, Youn JA, Bergman RN: Modified protocols to improve insulin sensitivity estimation using the minimal model. Am J Physiol. 1987, 253: E595-E602.

Brun JF, Guintrand-Hugret R, Boegner C, Bouix O, Orsetti A: Influence of short-term submaximal exercise on parameters of glucose assimilation analysed with the minimal model. Metabolism. 1995, 44: 833-840.

Gilman AG: In: The Pharmacological Basis of Therapeutics. Edited by: Hardman JG, Limbird LE. 1996, New York, McGraw-Hill, 1731-1734.

De Wit H, Griffiths RR: Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug and Alcohol Dependence. 1991, 28: 83-111. 10.1016/0376-8716(91)90054-3.

Rosenthal JM, Amiel SA, Yágüez L, Bullmore E, Hopkins D, Evans M, Pernet A, Reid H, Giampietro V, Andrew CM, et al: The effect of acute hypoglycemia on brain function and activation. A functional magnetic resonance imaging study. Diabetes. 2001, 50: 1618-1626.

Gram LF, Christensen L, Kristensen CB, Kragh-Sorensen P: Suppression of plasma cortisol after oral administration of oxazepam in man. Br J Clin Pharmacol. 1984, 17: 176-178.

Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C: Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry. 1991, 30: 73-80. 10.1016/0006-3223(91)90072-T.

Breier A, Charney DS, Heninger GR: Intravenous diazepam fails to change growth hormone and cortisol secretion in humans. Psychiatry Res. 1986, 18: 293-299. 10.1016/0165-1781(86)90014-4.

Calogero AE, Gallucci WT, Chrousos GP, Gold PW: Interaction between gabaergic neurotransmission and rat hypothalamic corticotropin releasing hormone secretion in vitro. Brain Res. 1988, 463: 28-36. 10.1016/0006-8993(88)90523-9.

Ambrosi F, Ricci S, Quartesan R, Moretti P, Pelicci G, Pagliacci C, Nicoletti I: Effects of acute benzodiazepine administration on growth hormone, prolactin and cortisol release after moderate insulin-induced hypoglycemia in normal women. Psychopharmacology. 1986, 88: 187-189.

Petraglia F, Baralakis S, Fachinetti F, Volpe A, Muller EE, Genazzani AR: Effects of sodium valproate and diazepam on beta-endorphin, beta-lipotropin and cortisol secretion induced by hypoglycemia stress in humans. Neuroendocrinology. 1986, 44: 320-325.

Östenson CG, Ahrén B, Karlsson S, Sandberg E, Efendic S: Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas. Regulatory Peptides. 1990, 29: 143-151. 10.1016/0167-0115(90)90077-A.

Östenson CG, Ahrén B, Johansson O, Karlsson S, Hilliges M, Efendic S: Diazepam binding inhibitor and the endocrine pancreas. Neuropharmacology. 1991, 30: 1391-1398.

Seyer-Hansen K: The effects of diazepam on glucose tolerance in rats. Diabetologia. 1972, 8: 66-67.

Pujalte D, Claeysen S, Dietz S, Chapal J, Hillaire-Buys D, Petit P: Inhibition of glucose-induced insulin secretion by a peripheral-type benzodiazepine receptor ligand (PK11195). Naunyn-Schmiedeberg's Arch Pharmacol. 2000, 362: 46-51.

Braestrup C, Squires R: Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H]diazepam binding. Proc Natl Acad Sci USA. 1977, 74: 3805-3809.

Najim RA, Al-Essa LY, Al-Jibouri LM: Effect of some drugs acting at the peripheral-type benzodiazepine receptors on blood glucose in mice. Med Sci Res. 1989, 17: 783-784.